Bahrain Pharmaceuticals & Healthcare Report Q4 2012 - New Market Research Report
BMI View: Per-capita spending on pharmaceuticals in Bahrain is expected to almost double in the 10 years to 2021, from some US$182 calculated for 2011, but will still remain a fraction of that in developed-country terms. Many multinational drug firms and other investors may continue to avoid Bahrain as the small size of the market will limit the potential return on their investment, especially given the unresolved political situation and the emergence of local manufacturing. Still, spending will generally remain...
View full press release